Genetic variants in the histone methylation and acetylation pathway and their risks in eight types of cancers

Genetic variants in the histone methylation and acetylation pathway and their risks in eight... INTRODUCTIONThe global cancer burden has continued to climb over the past decade. The development of cancer is thought to be a consequence of the accumulation of genetic alterations. Genome‐wide association studies evaluate genetic variants across the genome of different individuals to discern whether any one variant is related to a particular disease. The relation between single nucleotide polymorphisms (SNPs) and specific human diseases like cancer is a major focus of genome‐wide association studies. However, the analysis of the associations of a single site can explain only a small part of the genetic mechanism. Integrative analysis based on pathway levels can be used to investigate the cumulative relationship between a group of loci or genes and diseases.The epigenetic regulation of gene expression by histone modifications has recently been shown to be involved in cancer development. Histone methylation and acetylation are common histone modifications that play essential roles in the development of cancer. Reversible histone methylation and acetylation are important processes that are catalyzed by histone demethylases, histone methyltransferases, histone deacetylases and histone acetyltransferases. Aberrations in histone acetylation and methylation occur frequently in cancer, including changes in their distribution and levels in different genetic regions. Therefore, histone acetyltransferases, histone deacetylases, histone http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Digestive Diseases Wiley

Genetic variants in the histone methylation and acetylation pathway and their risks in eight types of cancers

10 pages
Read Article

Loading next page...
 
/lp/wiley/genetic-variants-in-the-histone-methylation-and-acetylation-pathway-BY9WwnScMg
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
© 2018 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd
ISSN
1751-2972
eISSN
1751-2980
D.O.I.
10.1111/1751-2980.12574
Publisher site
See Article on Publisher Site

Abstract

INTRODUCTIONThe global cancer burden has continued to climb over the past decade. The development of cancer is thought to be a consequence of the accumulation of genetic alterations. Genome‐wide association studies evaluate genetic variants across the genome of different individuals to discern whether any one variant is related to a particular disease. The relation between single nucleotide polymorphisms (SNPs) and specific human diseases like cancer is a major focus of genome‐wide association studies. However, the analysis of the associations of a single site can explain only a small part of the genetic mechanism. Integrative analysis based on pathway levels can be used to investigate the cumulative relationship between a group of loci or genes and diseases.The epigenetic regulation of gene expression by histone modifications has recently been shown to be involved in cancer development. Histone methylation and acetylation are common histone modifications that play essential roles in the development of cancer. Reversible histone methylation and acetylation are important processes that are catalyzed by histone demethylases, histone methyltransferases, histone deacetylases and histone acetyltransferases. Aberrations in histone acetylation and methylation occur frequently in cancer, including changes in their distribution and levels in different genetic regions. Therefore, histone acetyltransferases, histone deacetylases, histone

Journal

Journal of Digestive Diseases – Wiley

Published: Jan 1, 2018

Keywords: ; ;

References

  • Genetic alteration and gene expression modulation during cancer progression
    Garnis, C; Buys, TP; Lam, WL
  • Chapter 11: genome‐wide association studies
    Bush, WS; Moore, JH
  • Histone methylation: a dynamic mark in health, disease and inheritance
    Greer, EL; Shi, Y
  • Histone modifiers in cancer: friends or foes?
    Cohen, I; Poręba, E; Kamieniarz, K; Schneider, R
  • Epigenetic regulation of cancer growth by histone demethylases
    Lim, S; Metzger, E; Schüle, R; Kirfel, J; Buettner, R
  • Erasers of histone acetylation: the histone deacetylase enzymes
    Seto, E; Yoshida, M
  • Regulation of chromatin by histone modifications
    Bannister, AJ; Kouzarides, T
  • A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma
    Abnet, CC; Freedman, ND; Hu, N
  • Genome‐wide association study of prostate cancer identifies a second risk locus at 8q24
    Yeager, M; Orr, N; Hayes, RB
  • Principal components analysis corrects for stratification in genome‐wide association studies
    Price, AL; Patterson, NJ; Plenge, RM; Weinblatt, ME; Shadick, NA; Reich, D
  • A multi‐stage genome‐wide association study of bladder cancer identifies multiple susceptibility loci
    Rothman, N; Garcia‐Closas, M; Chatterjee, N
  • Genetic variants in the inositol phosphate metabolism pathway and risk of different types of cancer
    Tan, J; Yu, CY; Wang, ZH
  • Pathway analysis by adaptive combination of P‐values
    Yu, K; Li, Q; Bergen, AW
  • Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
    Haaften, G; Dalgliesh, GL; Davies, H
  • Aberrations of EZH2 in cancer
    Chase, A; Cross, NC
  • Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B‐cell lymphomas of germinal‐center origin
    Morin, RD; Johnson, NA; Severson, TM
  • Genetic variants in Fas signaling pathway genes and risk of gastric cancer
    Hyland, PL; Lin, SW; Hu, N
  • Genetic variants in sex hormone metabolic pathway genes and risk of esophageal squamous cell carcinoma
    Hyland, PL; Freedman, ND; Hu, N
  • Common genetic variants in epigenetic machinery genes and risk of upper gastrointestinal cancers
    Sung, H; Yang, HH; Zhang, H
  • Association between genetic variants in DNA and histone methylation and telomere length
    Kim, S; Parks, CG; Xu, Z
  • Tipping the lysine methylation balance in disease
    Black, JC; Whetstine, JR
  • Alterations of global histone H3K9 and H3K27 methylation levels in bladder cancer
    Ellinger, J; Bachmann, A; Göke, F
  • The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma
    Park, YS; Jin, MY; Kim, YJ; Yook, JH; Kim, BS; Jang, SJ
  • Decreased levels of histone H3K9me1 indicate poor prognosis in patients with renal cell carcinoma
    Rogenhofer, S; Kahl, P; Holzapfel, S; Ruecker, A; Mueller, SC; Ellinger, J
  • Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells
    Fodor, BD; Kubicek, S; Yonezawa, M
  • Histone demethylase JMJD2B is required for tumor cell proliferation and survival and is overexpressed in gastric cancer
    Li, W; Zhao, L; Zang, W
  • JMJD2B promotes epithelial‐mesenchymal transition by cooperating with β‐catenin and enhances gastric cancer metastasis
    Zhao, L; Li, W; Zang, W
  • Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma
    Northcott, PA; Nakahara, Y; Wu, X
  • A coding single‐nucleotide polymorphism in lysine demethylase KDM4A associates with increased sensitivity to mTOR inhibitors
    Van Rechem, C; Black, JC; Greninger, P
  • Influence of the KDM4A rs586339 polymorphism on overall survival in Asian non‐small‐cell lung cancer patients
    Marvalim, C; Wong, JX; Sutiman, N
  • Genetic polymorphisms in the Rb‐binding zinc finger gene RIZ and the risk of lung cancer
    Yoon, KA; Park, S; Hwangbo, B
  • Genetic variants in epigenetic genes and breast cancer risk
    Cebrian, A; Pharoah, PD; Ahmed, S
  • Dietary methyl donors, methyl metabolizing enzymes, and epigenetic regulators: diet–gene interactions and promoter CpG island hypermethylation in colorectal cancer
    Vogel, S; Wouters, KA; Gottschalk, RW
  • SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells
    Hamamoto, R; Furukawa, Y; Morita, M
  • Cooperation between SMYD3 and PC4 drives a distinct transcriptional program in cancer cells
    Kim, JM; Kim, K; Schmidt, T
  • SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma
    Liu, Y; Luo, X; Deng, J; Pan, Y; Zhang, L; Liang, H
  • SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma
    Zhu, Y; Zhu, MX; Zhang, XD
  • A SMYD3 small‐molecule inhibitor impairing cancer cell growth
    Peserico, A; Germani, A; Sanese, P
  • Upregulated SMYD3 promotes bladder cancer progression by targeting BCLAF1 and activating autophagy
    Shen, B; Tan, M; Mu, X
  • Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancer
    Reynoird, N; Mazur, PK; Stellfeld, T
  • A variable number of tandem repeats polymorphism in an E2F‐1 binding element in the 5′flanking region of SMYD3 is a risk factor for human cancers
    Tsuge, M; Hamamoto, R; Silva, FP
  • Identification of regulatory SNPs associated with genetic modifications in lung adenocarcinoma
    Lu, TP; Hsiao, CK; Lai, LC
  • MLL3, a new human member of the TRX/MLL gene family, maps to 7q36, a chromosome region frequently deleted in myeloid leukaemia
    Ruault, M; Brun, ME; Ventura, M; Roizès, G; De Sario, A
  • Altered expression of MLL methyltransferase family genes in breast cancer
    Rabello Ddo, A; Moura, CA; Andrade, RV; Motoyama, AB; Silva, FP
  • Mll3 genetic variants affect risk of gastric cancer in the Chinese Han population
    Li, B; Liu, HY; Guo, SH; Sun, P; Gong, FM; Jia, BQ
  • Interaction between MLL3 genetic polymorphisms, smoking, and alcohol drinking in laryngeal cancer: a case–control study
    Chen, D; Gong, L; Jiang, Q; Wang, X; Zhang, B
  • Frequent alteration of MLL3 frameshift mutations in microsatellite deficient colorectal cancer
    Watanabe, Y; Castoro, RJ; Kim, HS
  • Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma
    Balakrishnan, A; Bleeker, FE; Lamba, S
  • Somatic cancer mutations in the MLL3‐SET domain alter the catalytic properties of the enzyme
    Weirich, S; Kudithipudi, S; Kycia, I; Jeltsch, A
  • Association of MLL3 expression with prognosis in gastric cancer
    Li, B; Liu, HY; Guo, SH; Sun, P; Gong, FM; Jia, BQ
  • MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia
    Chen, C; Liu, Y; Rappaport, AR
  • Structural and functional conservation of the NuA4 histone acetyltransferase complex from yeast to humans
    Doyon, Y; Selleck, W; Lane, WS; Tan, S; Cote, J
  • KAT5 and KAT6B are in positive regulation on cell proliferation of prostate cancer through PI3K‐AKT signaling
    He, W; Zhang, MG; Wang, X
  • Expression of TIP60 (tat‐interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment‐specific outcome of localised invasive bladder cancer
    Laurberg, JR; Brems‐Eskildsen, AS; Nordentoft, I
  • Role of Tip60 in human melanoma cell migration, metastasis, and patient survival
    Chen, G; Cheng, Y; Tang, Y; Martinka, M; Li, G
  • TIP60 as a potential marker for the malignancy of gastric cancer
    Sakuraba, K; Yokomizo, K; Shirahata, A
  • Down‐regulation of Tip60 gene as a potential marker for the malignancy of colorectal cancer
    Sakuraba, K; Yasuda, T; Sakata, M
  • Targeted re‐sequencing identified rs3106189 at the 5′ UTR of TAPBP and rs1052918 at the 3′ UTR of TCF3 to be associated with the overall survival of colorectal cancer patients
    Shao, J; Lou, X; Wang, J
  • Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross‐contamination resulting in cell line redundancy and misidentification
    Schweppe, RE; Klopper, JP; Korch, C
  • The MYST family of histone acetyltransferases and their intimate links to cancer
    Avvakumov, N; Côté, J
  • Status of epigenetic chromatin modification enzymes and esophageal squamous cell carcinoma risk in northeast Indian population
    Singh, V; Singh, LC; Singh, AP
  • Identification of MYST3 as a novel epigenetic activator of ERα frequently amplified in breast cancer
    Yu, L; Liang, Y; Cao, X
  • The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB‐binding protein
    Borrow, J; Stanton, VP; Andresen, JM
  • Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation
    Kitabayashi, I; Aikawa, Y; Yokoyama, A
  • Comprehensive profiling of 8p11‐12 amplification in breast cancer
    Gelsi‐Boyer, V; Orsetti, B; Cervera, N
  • KAT6A, a chromatin modifier from the 8p11‐p12 amplicon is a candidate oncogene in luminal breast cancer
    Turner‐Ivey, B; Guest, ST; Irish, JC
  • Tumor evolution and intratumor heterogeneity of an oropharyngeal squamous cell carcinoma revealed by whole‐genome sequencing
    Zhang, XC; Xu, C; Mitchell, RM
  • Altered DNA methylation profile in Norwegian patients with autoimmune Addison's disease
    Bjanesoy, TE; Andreassen, BK; Bratland, E
  • Class IIa histone deacetylases: regulating the regulators
    Martin, M; Kettmann, R; Dequiedt, F
  • Down‐regulation of HDAC5 inhibits growth of human hepatocellular carcinoma by induction of apoptosis and cell cycle arrest
    Fan, J; Lou, B; Chen, W
  • The many roles of histone deacetylases in development and physiology: implications for disease and therapy
    Haberland, M; Montgomery, RL; Olson, EN
  • HDAC5 promotes colorectal cancer cell proliferation by up‐regulating DLL4 expression
    He, P; Liang, J; Shao, T; Guo, Y; Hou, Y; Li, Y
  • No association between polymorphisms in the histone deacetylase genes and the risk of lung cancer
    Park, JM; Lee, GY; Choi, JE
  • Differential expression of selected histone modifier genes in human solid cancers
    Ozdağ, H; Teschendorff, AE; Ahmed, AA
  • Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib
    Lachenmayer, A; Toffanin, S; Cabellos, L
  • SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation
    Barber, M; Michishita‐Kioi, E; Xi, Y
  • High expression of Sirt7 served as a predictor of adverse outcome in breast cancer
    Geng, Q; Peng, H; Chen, F; Luo, R; Li, R
  • Hsa‐miR‐125b suppresses bladder cancer development by down‐regulating oncogene SIRT7 and oncogenic long non‐coding RNA MALAT1
    Han, Y; Liu, Y; Zhang, H
  • MicroRNA‐3666‐induced suppression of SIRT7 inhibits the growth of non‐small cell lung cancer cells
    Shi, H; Ji, Y; Zhang, D; Liu, Y; Fang, P
  • SIRT7 exhibits oncogenic potential in human ovarian cancer cells
    Wang, HL; Lu, RQ; Xie, SH
  • Association between SIRT1 gene polymorphisms and breast cancer in Egyptians
    Rizk, SM; Shahin, NN; Shaker, OG
  • Association of SIRT1 gene variation with visceral obesity
    Peeters, AV; Beckers, S; Verrijken, A
  • SIRT1 genetic variation and mortality in type 2 diabetes: interaction with smoking and dietary niacin
    Zillikens, MC; Meurs, JB; Sijbrands, EJ
  • SIRT1 gene, age‐related diseases, and mortality: the Leiden 85‐plus study
    Kuningas, M; Putters, M; Westendorp, RG; Slagboom, PE; Heemst, D

You’re reading a free preview. Subscribe to read the entire article.

Try 2 weeks free now

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

or browse the journals available

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off

Sign up
for free
Start 14 day
Free Trial